No results for ‘’
Astec Lifesciences Ltd
₹797.70
(0.48%)
Wed, 24 Jun 2026, 03:58 am
Process Industries
Chemicals: Agricultural
24.5KAstec Lifesciences Return on Equity (ROE) History
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 4.47 | 15.92 | 36.30 | 4.93 | 7.85 | 19.38 | 76.77 | 61.70 | 32.61 | 29.50 | 16.48 | 30.12 | 38.22 | 106.03 | 0 | 0 |
| Price to book ratio | 0 | 0.89 | 0.80 | 0.51 | 0.29 | 0.60 | 2.11 | 3.21 | 8.53 | 6.70 | 5.20 | 3.17 | 6.34 | 8.66 | 6.46 | 5.64 | 5.64 |
| Price to sales ratio | 0 | 0.53 | 0.71 | 0.44 | 0.17 | 0.33 | 1.08 | 1.66 | 4 | 3.15 | 2.45 | 1.50 | 3.53 | 5.08 | 4.32 | 4.54 | 3.48 |
| Price to cash flow ratio | 0 | 8.73 | 5.57 | 10.58 | 2.83 | 6.67 | 47.32 | 0 | 159.69 | 20.87 | 322.19 | 5.03 | 0 | 228.64 | 46.20 | 0 | 0 |
| Enterprise value | 0 | 94.1Cr | 119Cr | 106Cr | 93.86Cr | 146Cr | 373Cr | 501Cr | 1301Cr | 1261Cr | 1229Cr | 880Cr | 2145Cr | 3712Cr | 3050Cr | 2574Cr | 1875Cr |
| Enterprise value to EBITDA ratio | 0 | 3.69 | 7.55 | 6.27 | 3.26 | 3.95 | 6.84 | 14.54 | 20.72 | 20.02 | 15.60 | 10.18 | 19.04 | 23.88 | 38.77 | 0 | 0 |
| Debt to equity ratio | 1.36 | 0.40 | 0.45 | 0.73 | 0.66 | 0.73 | 0.73 | 1.08 | 0.92 | 0.73 | 0.87 | 0.40 | 0.61 | 0.70 | 0.81 | 1.34 | 2.36 |
| Return on equity % | 0 | 21.11 | 5.17 | 1.40 | 5.83 | 7.91 | 11.88 | 3.92 | 15 | 22.69 | 19.21 | 21.16 | 23.41 | 25.47 | 6.26 | -11.89 | -44.61 |
Astec Lifesciences Ltd Return on Equity
The Astec Lifesciences Ltd Return on Equity is a key financial metric used by investors to evaluate Astec Lifesciences Ltd's valuation, profitability, and overall financial performance. Tracking the Astec Lifesciences Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Astec Lifesciences Ltd (NSE: ASTEC, BSE: 533138) is currently trading at ₹797.70, with a market capitalization of ₹1776.16Cr. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Astec Lifesciences Ltd Return on Equity is essential for fundamental analysis.
Astec Lifesciences Ltd Return on Equity Current Value
The current Astec Lifesciences Ltd Return on Equity stands at -44.61.
The Astec Lifesciences Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Astec Lifesciences Ltd Return on Equity Historical Trend
The Astec Lifesciences Ltd Return on Equity has shown the following historical trend:
- 2024: -44.61
- 2023: -11.89
- 2022: 6.26
- 2021: 25.47
- 2020: 23.41
The decline in Astec Lifesciences Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Astec Lifesciences Ltd Return on Equity Indicates for Investors
The Astec Lifesciences Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Astec Lifesciences Ltd Return on Equity Analysis Summary
The Astec Lifesciences Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Astec Lifesciences Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Astec Lifesciences Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.